Stroke News

BOSTON — In patients with postinfarction ventricular septal defects, percutaneous and surgical treatments reduced mortality rates compared with historical medical therapy data, researchers reported at TCT 2022.

BOSTON — At 3 years, the Amplatzer Amulet device remained superior at left atrial appendage occlusion and noninferior for safety and effectiveness compared with the Watchman device, researchers reported at TCT 2022.

RANCHO PALOS VERDES, Calif. — In this Healio video exclusive, Ulrika Birgersdotter-Green, MD, discusses the “unique differences” between men and women with atrial fibrillation.

Statin therapy after ischemic stroke is associated with improved survival and may be particularly beneficial in patients with a history of cancer, according to a brief report published in Stroke.

Anthos Therapeutics announced abelacimab, a fully human monoclonal antibody inhibiting factor XI, received fast track designation from the FDA for an indication to prevent stroke and systemic embolism in patients with atrial fibrillation.

Immune checkpoint inhibitor therapy appeared associated with an increased risk for major adverse cardiovascular events among patients with cancer and a prior history of cardiovascular disease, according to results of a retrospective study.

Boston Scientific announced the FDA indication for its left atrial appendage closure device has been expanded to include a 45-day dual antiplatelet therapy option after treatment of patients with nonvalvular atrial fibrillation.

Asundexian on top of dual antiplatelet therapy successfully reduced factor XIa activity after acute MI and stroke with no excess bleeding risk, two speakers reported.

History of stroke was associated with increased odds of cognitive impairment in both non-Hispanic white and Mexican American individuals, researchers reported.

Influenza vaccination rates were low in younger patients with CVD despite having the opportunity to be vaccinated at no cost, researchers reported in the European Heart Journal – Quality of Care & Clinical Outcomes.